Department of Neurology, Experimental Neurology, Heinrich Heine University Düsseldorf, Merowingerplatz 1a, 40225 Düsseldorf, Germany.
Cell Tissue Res. 2012 Jul;349(1):79-85. doi: 10.1007/s00441-011-1302-7.
Like other neurons of the central nervous system (CNS), retinal ganglion cells (RGCs) are normally unable to regenerate injured axons and instead undergo apoptotic cell death. This regenerative failure leads to lifelong visual deficits after optic nerve damage and is partially attributable to factors located in the inhibitory environment of the forming glial scar and myelin as well as to an insufficient intrinsic ability for axonal regrowth. In addition to its ophthalmological relevance, the optic nerve has long been used as a favorable paradigm for studying regenerative failure in the CNS as a whole. Findings over the last 15 years have shown that, under certain circumstances, mature RGCs can be transformed into an active regenerative state enabling these neurons to survive axotomy and to regenerate axons in the optic nerve. Moreover, combinatorial treatments overcoming the inhibitory environment of the glial scar and optic nerve myelin, together with approaches activating the intrinsic growth program, can further enhance the amount of regeneration in vivo. These findings are encouraging and open the possibility that clinically meaningful regenerationmay become achievable in the future.
与中枢神经系统 (CNS) 中的其他神经元一样,视网膜神经节细胞 (RGC) 通常无法再生受损的轴突,而是会发生细胞凋亡。这种再生失败导致视神经损伤后终生视力缺陷,部分原因是形成胶质瘢痕和髓鞘的抑制性环境中的因素以及轴突再生的内在能力不足。除了其眼科相关性外,视神经长期以来一直被用作研究整个中枢神经系统再生失败的有利范例。过去 15 年的研究结果表明,在某些情况下,成熟的 RGC 可以转变为活跃的再生状态,使这些神经元能够在轴突切断后存活并在视神经中再生轴突。此外,克服胶质瘢痕和视神经髓鞘抑制性环境的组合治疗方法,以及激活内在生长程序的方法,可进一步增强体内的再生量。这些发现令人鼓舞,为未来实现有临床意义的再生提供了可能性。